Ridgeback Capital Investments L.P. Quant / Systematic

Name: Ridgeback Capital Investments L.P. Q4 2015 13F Filing | 13F Explorer
Creator: Ridgeback Capital Investments L.P.
Published: 2016-02-16

Location: Miami Beach, FL

CIK: 0001423994 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $23.24M (100.0% shares, 0.0% debt)

Holdings (4)

— CARA THERAPEUTICS, INC. 45.1%

Value $10.49M Shares 622,140 Est. Cost $16.86 Unrealized —

— APPLIED GENETIC TECHNOLOGIES INC. 21.6%

Value $5.019M Shares 246,005 Est. Cost $21.02 Unrealized —

— TRILLIUM THERAPEUTICS INC. 20.1%

Value $4.672M Shares 370,537 Est. Cost $12.61 Unrealized —

— ONCOSEC MEDICAL INC. 13.2%

Value $3.063M Shares 1,292,614 Est. Cost $2.37 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	CARA THERAPEUTICS, INC.	622,140	$10.49M	45.1%	$16.86	—	COM	140755109
—	APPLIED GENETIC TECHNOLOGIES INC.	246,005	$5.019M	21.6%	$21.02	—	COM	03820J100
—	TRILLIUM THERAPEUTICS INC.	370,537	$4.672M	20.1%	$12.61	—	COM	89620X506
—	ONCOSEC MEDICAL INC.	1,292,614	$3.063M	13.2%	$2.37	—	COM	68234L207